2-[(1E,3E,5Z)-5-(1-{6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl}-3,3-dimethyl-5-sulfo-1,3-dihydro-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-3H-indolium-5-sulfonate（CAS番号：146368-14-1）

2-[(1E,3E,5Z)-5-(1-{6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl}-3,3-dimethyl-5-sulfo-1,3-dihydro-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-3H-indolium-5-sulfonate

基本情報

編集器で閲覧

CAS番号

146368-14-1

分子式

C37H43N3O10S2

分子量

753.88 g/mol

化学分類

基礎化学原料有機化学品カルボン酸類

基礎化学原料有機化学品複素環化合物

医薬化学品医薬中間体複素環中間体

精密化学品染料および顔料有機染料

精密化学品界面活性剤アニオン性界面活性剤

実験室化学品研究用化学品生化学試薬

基本的な物理特性

SMILES

編集器で閲覧

CC[N+]1=C(C(c2c1ccc(c2)S(=O)(=O)[O-])(C)C)/C=C/C=C/C=C\3/C(c4cc(ccc4N3CCCCCC(=O)ON5C(=O)CCC5=O)S(=O)(=O)O)(C)C

InChI

InChI=1S/C37H43N3O10S2/c1-6-38-29-18-16-25(51(44,45)46)23-27(29)36(2,3)31(38)13-9-7-10-14-32-37(4,5)28-24-26(52(47,48)49)17-19-30(28)39(32)22-12-8-11-15-35(43)50-40-33(41)20-21-34(40)42/h7,9-10,13-14,16-19,23-24H,6,8,11-12,15,20-22H2,1-5H3,(H-,44,45,46,47,48,49)

InChIKey

WXWLHDCCGVWTDZ-UHFFFAOYSA-N

複雑度

1720

安全情報

安全情報を表示

危険性の表示

H302 飲み込むと有害
急性毒性（経口）

H317 アレルギー性皮膚反応を起こすおそれ
感作性（皮膚）

同義語と引用データ

英語

3H-Indolium,2-[5-[1-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-,inner salt
3H-Indolium,2-[5-[1-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-p
Cy5 NHS Ester
Cy5-SE
Cy5-succinimidyl ester
3H-Indolium,2-[5-[1-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadienyl]-1-ethyl-3,3-dimethyl-5-sulfo-,inner salt
Cy 5.29OSu
Cy5
Fluorolink Cy5
FluoroLink Mono Reactive DyeCy5
CY 5-NHS
Cyanine 5
CY6-SE
Sulfo-Cy5-SE
Cyanine5 NHS ester
CY5 NHS ESTER,Cy5-SE
Cyanine 5 monosuccinimidyl ester [equivalent to Cy5 NHS ester]
2-(5-(1-(6-((2,5-Dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium-5-sulfonate
Cyanine 5, SE
2-[5-[1-[6-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-3H-indolium, inner salt
(2Z)-2-[(2E,4Z)-5-[1-[6-(2,5-Dioxopyrrolidin-1-yl)oxy-6-oxohexyl]-3,3-dimethyl-5-sulfoindol-1-ium-2-
CY5-SE